Bearing in mind the role of somatostatin in thymus functions
Bearing in mind the role of somatostatin in thymus functions, and changes of somatostatin level and expression of its receptors during postnatal life, the aim of this study was to investigate whether centrally applied SRIH-14 induces different changes in the thymic compartments and thymocyte profile in peripubertal and young adult rats. To this end, 4-and 10-week-old male AO rats were cannulated and treated intracerebroventriculary with three doses of SRIH-14, applied every other day. In peripubertal rats, SRIH-14 decreases thymic relative weight and volume, as well as the volume of thymic compartments

INTRODUCTION
Thymus is a primary lymphoid organ that provides a specialized microenvironment for the development of thymocytes and their maturation into functional T cells. During development thymocytes pass through a series of distinct phases marked by changes in the status of the T cell-receptor (TCR) gene Dardenne, 2000) . Because GH stimulates thymocytes development and/or survival its reduced concentration in puberty can be associated with thymic atrophy (Dominguez-Grepe and Rey- Mendeze, 2003) . Principal support of the hypothesis that hormones contributes to thymic atrophy and is based on studies demonstrating an increase of thymic cellularity after GH administration, in old mice (Murphy et al., 1992) . However, results obtained in little (lit) strain of mice suggest that hormonal level changes are not responsible for thymic atrophy (Min et al., 2006) .
Considering opposing results obtained for influence of hormones on triggering thymic atrophy, as well as data about changes in sstr expression, but not in affinity, on thymic cells during postnatal life (Ferone et al., 2002; Taub and Longo, 2005) we investigated whether centrally applied SRIH-14 induce different changes in the thymus of peripubertal and young adult rats and if it does whether these changes at investigated ages contribute to thymic atrophy.
MATERIAL AND METHODS
Experimental animals
Male rats of Albino Oxford (AO) strain, 4-and 10-weeks old, were used in this study. Animals were housed in our animal colony according to standard conditions, and following current guidelines for the care and use of laboratory animals. The operational procedure of cannulation was performed under total Nembutal anaesthesia (35 mg/kg, intraperitonel, Serve Feinbiochemica, Heidelberg). The anesthetized rats were latched in a stereotaxic apparatus (La Precision Cinematographique, France) and a skin incision was made between the bregma and lambda. The connective tissue over the periost was removed and a cannula impregnated with silicone was inserted into the brain ventricle. Stereotaxic coordinates for cannulations were 2 mm lateral to the sagittal suture, 2 mm caudal to the frontal suture and 3.2 mm ventral to the surface of the cortex. The cannula was affixed to the skull by two metal screws and dental acrylic (Simgal, Galenika, Beograd). Rats were placed in individual cages and allowed to recover for at least one week before being introduced into the experiments.
Protocol
After recovery, animals from each age group received three doses of SRIH-14 (1 µg/5 µL saline; HPLC purity 97%, Sigma, S-9129), with 48-h intervals between treatments. The control group of peripubertal and young adult rats was treated with 5 µL of saline in the same manner as experimental animals. All groups contained 10 animals. The permeance and placement of the cannulas was examined by vital dye tested on the day when the animals were sacrificed. Only animals with a confirmed position in the lateral ventricle were considered for analysis.
The animals were sacrificed 24 h after the last treatment and their thymuses were removed, weighed and processed for flow cytometric analysis (FCA) or for stereological analyses. 
Preparation of cell suspensions
Single cell suspensions of freshly isolated thymuses were obtained by grinding the thymus tissue between the frosted glass slides. After washing three times with ice-cold PBS (pH 7.3; containing 2% FCS and 0.01% sodium aside), cells were counted with a hemocytometer and cell viability, determined by Trypane blue dye exclusion, was >95%. Apoptosis was analyzed using the Merocyanine 540 (1 mg/mL redistilled; Sigma). All samples were analysed on the flow cytometer using Consort 30 software program.
Flow Cytometry
Morphometry
The thymuses were weighted and snap frozen in cryostat embedding media (Reichert, Wien, Austria). The serial sections of the thymuses, 5 µm thickness, stained with hematoxylin and eosin were analyzed by Olympus BH2 microscope.
The volume of the thymic cortex, medulla and interlobular connective tissue, as well as numerical density (Nv) of thymocytes, in the outer/deep cortex and medulla were determined on every tenth section of the gland, from each rat, using a multipurpose test system M 42 (Weibel, 1979) . For each investigated structure, the size of the final sample was determined, within the confidence interval of <95%.
Statistical analysis
The results were expressed as the mean values ± SD. Values were compared by nonparametric Mann-Whitney U test using the program SPSS 10 for Windows. Differences at p<0.05 were accepted as the level of significance.
RESULTS
SRIH-14 induced similar changes in peripubertal and adult rats of the body and thymus weight, but not in relative thymus weight
In both age groups of rats treated with SRIH-14, the body weight was significantly reduced compared to corresponding values in control rats of the same age. The reduction of body weight was on the level significance of p<0.05 in both treated groups (Fig. 1a) . The average thymus weight in both age groups was decreased, but in peripubertal rats more (p<0.01) than in young adults (p<0.05; Fig. 1b ). The relative thymus weight, obtained by calculation from the proportion of thymus and body weight, was significantly reduced in peripubertal rats (p<0.05), while in the young adults was unchanged ( 
Variations in thymic cellularity and thymic compartments volume in SRIH-14 treated rats of different ages
Reduction of thymus weight might outcome from the changes of thymus size and/or cellularity. The obtained results showed that SRIH-14 significantly decreased the thymic volume in peripubertal rats, while in the young adults the thymic volume decrease was not significant (Fig 2a) . Statistically important decrease of thymocytes total yield was observed in both experimental groups compared to age-matched controls, although the mentioned decrease was larger in peripubertal rats (p<0.01 in peripubertal; p<0.05 in young adults; Fig. 2b) . SRIH-14, in peripubertal and young adult rats, also decreased the absolute numbers of cortical thymocytes compared to the corresponding controls. Considering that one quarter of the cortical thymocytes belongs to the outer and three quarters to the deep cortex, we determined the numerical density of thymocytes in these cortical compartments, in order to explain which part of the cortex participated in alterations of the cortical thymic numbers. The results showed a slightly increased numerical density of thymocytes within the outer cortex and a significantly decreased (p<0.001) cell number within the deeper cortex of peripubertal rats treated with SRIH-14 compared to controls (Fig. 3) . This neuropeptide, applied in young adult rats, significantly reduced the mean numerical density of thymocytes within both cortical compartments (Fig. 3) . Bearing in mind the importance of thymus compartments in the process of thymocytes differentiation, we investigated whether application of SRIH-14 evoked morphometric changes in the thymus compartments. The results revealed that SRIH-14 significantly reduced (p<0.05) the volume of the thymic cortex and medulla in peripubertal rats, while in young adults only the thymic cortex volume was significantly affected (p<0.05; Fig. 4 ).
SRIH-14 increased the percentage of apoptotic cells in both experimental groups
To evaluate whether treatment with SRIH-14 changes the percentage of apoptotic cells, Merocyanine 540 staining method was used. The results showed that the percentage of apoptotic cells was increased in both experimental groups compared to age-matched controls, and it was statistically significant (p<0.05; The results of this study showed that SRIH-14 treatment alters the relation among thymocyte subpopulations. The mentioned neuropetide increased the percentage of thymocytes within the double negative (DN) subpopulation and both single positive (SP) subpopulations (p<0.01), while reduced the relative proportion of double positive (DP) thymocytes (p<0.05; Table 1 ), in the both experimental groups compared to adequate controls.
Analysis of twelve thymocyte subsets revealed that SRIH-14, in both treated groups, increased the percentage of thymocytes with undetectable and low level of TCRab expression (TCRab -/low ) within the DN thymocytes subpopulation compared to corresponding control animals. In addition, SRIH also significantly increased the relative proportion of DN TCRab hi thymocytes, but only in young adult rats (Table 1) . + thymocytes subpopulation, was also increased in the young adult rats treated with SRIH-14, while the remaining two subsets (SP CD4 + TCRab -/low ) were not significantly changed (Table 1) .
DISCUSSION
Our results clearly showed that SRIH-14 induced a decrease of thymic weight and cellularity i.e. thymic atrophy in both age groups, but these changes had a significantly higher degree in peripubertal rats compared to young adults. In addition, somatostatin-14 in peripubertal rats increased the number of immature thymocytes as a result of changes in the thymocytes transition from the DN to DP stage, while in young adults it modulates transition of DP cells into mature SP cells.
Reduction of thymic weight and cellularity induced by SRIH-14, directly over sstr expressed in the thymus (Ferone et al., 2002; Petrovic-Djergovic et al., 2007) , and/or indirectly by inhibition of GH secretion (Milosevic et al., 1996) , is in the line with the data obtained in the Ames mice, deficient in GH and PRL secretion (Duqesnoy, 1972) . These observations imply the involvement of pituitary hormones in the process of thymic atrophy, also called thymic involution (Taub and Longo, 2005) . Likewise, the elevated absolute and relative thymic weight in the Ames mice, hypophysectomized rats and old mice treated with PRL, GH and IGF-I (Smith, 1930; Murphy et al., 1992; Montecino-Rodriguezet et al., 1998; Dorshkind and Horseman, 2000) indicate the association between thymic atrophy and decline in hormone levels.
Thymic involution commences at the time of puberty as the level of sex steroid hormones increases and the production of growth hormone (GH) and insulin-like growth factor-I (IGF-I) decreases (Utsuyama and Hirokaw, 1989; Domínguez-Gerpe and Rey-Méndez, 2003; Taub and Longo, 2005) . Thymic involution is a slow physiological process that can be accelerated by some pathological or experimental conditions (Báez-Saldaña and Ortega, 2004). Thus, our results (i.e. reduction of relative thymic weight and cellularity) indicate that application of SRIH-14 in peripubertal rats accelerates the reduction in thymus size. In contrast, in young adults this neuropeptide has inhibiting effects not only on the thymus, but also on the whole body. The diminished size of multiple tissues such as muscle and bone, as a consequence of reduced circulating GH and IGF-1 levels during ageing, supports our finding (Rudman et al., 1990) .
Our results also suggest that the decreased numerical density of thymocytes in deep cortex and diminished thymocytes number in the thymic cortex and medulla (quantitatively more in the cortex), contributes to the reduction of total thymocytes count in both experimental groups. Literature data imply that this decrease may happen due to reduced entry of the thymocytes precursors into the thymus (Savino and Dardenne, 2000; Savino et al., 2002) , reduced proliferation rates and massive cell death of thymocytes in the areas of the cortex (Steinmann, 1986; Sharma et al., 1996; Ferone et al., 2004) . Increased apoptosis of thymocytes in SRIH-14 treated animals, induced over its receptors expressed on immature thymocytes (Ferone et al., 2002; , probably is the one of the factors which contributes to the reduction of thymocytes numerical density in the thymic cortex. Bearing in mind that the loss of thymocytes is among the first alterations which occur in the thymus during physiological involution (Steinman, 1986) the results obtained in our study suggest that SRIH-14 may contribute to the mentioned physiological phenomenon.
In addition, SRIH-14 has opposite effects on the numerical density of thymocytes within the subcapsular region in peripubertal and young adult rats. In peripubertal rats the mentioned neuropeptide increased the numerical density of thymocytes within the subcapsular region as a consequence of accumulation of the most immature thymocytes (DN TCRab -/low ). Interestingly, our results show that the least mature thymocyte subset contains a minor, but significantly increased population of immature SP TCRab -/low cells, which have intermediate characteristics between the CD4-CD8-cells and CD4 + CD8
+ cells (Takeuchi et al., 1993) . The expression of sst3 receptor mRNA on the intermedial/mature CD3 + thymocytes indicates that these cells, at least, partially contribute to SRIH mediated apoptosis (Ferone et al., 2002 (Ferone et al., , 2004 Sharma et al., 1996) . On the other hand, the tenfold increased percentage of DN TCRab low thymocytes undergoing apoptosis (Kersh and Hedrick, 1995) might be the reason for the decrease of thymocytes numerical density in the subcapsular cortex of young adults. Different changes in the numerical density of thymocytes within the subcapsular region in peripubertal and young adult rats might be due to the distinct distribution of sst receptors in thymocytes subsets and a reduction of sstr number during postnatal life (Ferone et al., 2000) .
As a consequence of the early T-cell development block, the thymus contains atypically arranged cortical TECs, and lacks an organized medulla (Hollander et al., 1995) . Taking into account that the three-dimensional organization and maintenance of the thymic cortical microenvironment is dependent upon signals from differentiating thymocytes (Mohtashami and Zúñiga-Pflücker, 2006) , the reduced number of cortical thymocytes in both treated groups could cause the reduction in the thymic cortex volume, as a consequence of the loss of the fine stromal cells network. On the other hand, the mature T cells are involved in maintenance of the correct medullar microenvironment (Shores et al., 1994) , and the reduction of the thymic medulla volume in peripubertal rats may be associated with the decrease of SP CD8 (Starr et al., 2003) , indicate that SRIH-14 in peripubertal rats may be involved in the backlash positive selection.
On the other hand, in the young adult rats, increase of DN TCRab -/low cells and decrease of DP TCRab -subset, direct precursor of DP TCRab low cells, indicates that SRIH-14 alters DN to DP transition and induces the loss of the cells with unsuccessfully rearrangement of b chain by apoptosis (Starr et al., 2003) . Somatostatin increases a minor subset of DN TCRab hi expressing cells, also. These cells represent distinct lineage cells, in adult mice, that do not follow the conventional process of selection (Budd and Mixter, 1995) . In co-culture with naïve T cells and antigens, these cells express immunoregulatory activity (Wang et al., 2002) . The presence of DN T regulatory cells in the lymph nodes and spleen of thymectomized mice reconstituted with T cell-depleted bone marrow cells suggest that these regulatory cells may preferentially develop outside the thymus (Ford et al., 2006) . Changes in the proportion of DP TCRab hi and both SP TCRab hi thymocytes suggest that SRIH-14 accelerates positive selection and maturation of selected thymocytes preferentially towards SP CD8 + TCRab hi cells.
CONCLUSIONS
In conclusion, the accumulation of immature cells and decrease of the percentage of cells that have to pass through positive selection, observed in the peripubertal rats, as well as an increase the percentage of DNTCRab hi cells and modulation of maturation of selected thymocytes, preferentially towards SPCD8 cells, found in the young adult rats, suggest that SRIH-14 has different effects on thymocytes maturation depending on age. In addition, the decrease of the thymic relative weight measured in peripubertal rats indicates that SRIH-14, although is not a critical factor for thymic involution, contributes its atrophy.
vodi do razli~itih promena u zonama timusa i profilu timocitnih subsetova. Mu`jacima pacova AO soja, starim 4 i 10 nedelja, ugra|ene su kanile u tre}u mo`danu komoru i oni su tretirani somatostatinom, ukupno tri doze, ubrizgane svakog drugog dana. U prepubertalnih pacova tretman somatostatinom dovodi do smanjenja relativne mase i zapremine timusa, kao i zapremine timusnih zona, naro~ito dubokog korteksa, {to je bila posledica gubitka timocita apoptozom. Tako|e, SRIH-14 je doveo do pove}anja procenta timocita nezrelog fenotipa (DNTCRab -/low , DPTCRab -, SPCD8TCRab -/low i SPCD4TCRab -/low ) prekusora DPTCRab low subpopulacije, smanjenja procenta DPTCRab low i DPTCRab hi subsetova, dok je relativni odnos najzrelijih CD4TCRab hi i CD8TCRab hi timocita ostao neizmenjen. U mladih adulta primena somatostatina, iako dovodi do smanjena zapremine i celularosti korteksa ne dovodi do promena u relativnoj masi timusa. Procenat DPTCRab -/ hi timocita je bio smanjen, dok je procentualno u~e{}e DNTCRab hi timocita i obe jednostruko pozitivne subpopulacije (CD4TCRab hi i CD8TCRab hi , vi{e CD8TCRab hi ) u ukupnom broju timocita bilo pove}ano. Navedeni rezultati ukazuju da SRIH-14 razli~ito uti~e na morfologiju timusa i na subpopulacije timocita pacova u zavisnosti od uzrasta tretiranih`ivotinja.
